Skip to main content

and
  1. Article

    Open Access

    Request for clarification from Ruiter et al regarding ‘Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study’. Reply to Carstensen B [letter]

    R. Ruiter, L. E. Visser, B. H. Ch. Stricker in Diabetologia (2012)

  2. Article

    Open Access

    Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study

    Several publications suggest an association between certain types of insulin and cancer, but with conflicting results. We investigated whether insulin glargine (A21Gly,B31Arg,B32Arg human insulin) is associate...

    R. Ruiter, L. E. Visser, M. P. P. van Herk-Sukel, J. W. W. Coebergh in Diabetologia (2012)

  3. Article

    Genetic variation in the NOS1AP gene is associated with the incidence of diabetes mellitus in users of calcium channel blockers

    M. L. Becker, L. E. Visser, C. Newton-Cheh, J. C. M. Witteman, A. Hofman in Diabetologia (2008)

  4. No Access

    Article

    Repeated nitrate prescriptions as a potential marker for angina pectoris A comparison with medical information from the Rotterdam Study

    Objective: The objective of this study was to determine whether pharmacy records of nitrate prescriptions could be used as a marker of angina pectoris.Method: This study was conducted within the Rotterdam Study,...

    A.H. Maitland‐van der Zee, O.H. Klungel, H.G.M. Leufkens in Pharmacy World and Science (2003)

  5. No Access

    Article

    Utilisation of malaria prophylaxis: the effect of changes in guidelines in the Netherlands, 1993‐1998

    Introduction: The increase in international travelling from temperate zones to tropical countries and increasing drug resistance of Plasmodium falciparum has resulted in a growing number of travellers that are a...

    M.M. van Riemsdijk, M.C.J.M. Sturkenboom, H.J. Schilthuis in Pharmacy World and Science (2003)

  6. No Access

    Article

    Evaluation of antiparkinsonian drugs in pharmacy records as a marker for Parkinson's disease

    Aim: The aim of this study was to determine whether use of antiparkinsonian drugs in pharmacy records can be used as a marker for patients with Parkinson's disease (PD). Method: Data were obtained from the Rotte...

    D.A.M.C. van de Vijver, A.J. Porsius, A. de Boer in Pharmacy World and Science (2001)

  7. No Access

    Article

    Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands

    Introduction: Shortly after their introduction, fluoroquinolones were associated with reports of tendinitis and tendon rupture. During the past years, the number of reports has risen, possibly because of an incr...

    P.D. van der Linden, B.H.Ch Stricker, H.G.M. Leufkens in Pharmacy World and Science (2001)

  8. No Access

    Article

    Abstracts of papers and posters

    C. C. M. Veninga, P. Denig, F. M. Haaijer-Ruskamp in Pharmacy World and Science (1995)

  9. No Access

    Article

    Abstracts of papers and posters Meeting on Pharmaceutical Sciences

    Russell C. Coile Jr., K. Wiedhaup, Ilva van Bommel in Pharmacy World and Science (1993)

  10. No Access

    Article

    Abstracts of papers and posters Clinical Pharmacological Meeting

    C. A. Verhagen, H. Mattie, E. van Strijen in Pharmacy World and Science (1993)

  11. No Access

    Article

    Abstracts of papers clinical pharmacological meeting

    M. M. van der Klauw, B. H. Ch. Stricker, J. P. Ottervanger in Pharmacy World and Science (1993)

  12. No Access

    Article

    Abstracts of papers Rational use of drugs

    M. N. G. Dukes, Robert M. Elenbaas pharm.D.,FCCP, G. Tognoni in Pharmaceutisch Weekblad (1989)

  13. No Access

    Article

    Abstracts of Dutch doctoral theses

    M. J. A. P. Daemen, B. H. Ch. Stricker, R. Van De Straat in Pharmaceutisch Weekblad (1988)

  14. Article

    Hepatitis bij gebruik van glafenine

    Five case-histories have been reported to the Netherlands Centre for Monitoring of Adverse Reactions to Drugs concerning patients with hepatitis, attributed to the use of glafenine (including two previously pu...

    B. H. Ch. Stricker, R. H. B. Meyboom in Pharmaceutisch weekblad (1979)